PRESS RELEASESModerna Completes Enrollment Of Phase 2 Study Of Its MRNA Vaccine Against COVID-19 (mRNA-1273)By Business WireJul 8, 2020 9:44 AM EDT
INVESTINGTrading Regeneron as It Hits New Highs on Government’s $450M DealBy Bret KenwellJul 7, 2020 1:15 PM EDT
PRESS RELEASESFlagship Pioneering's Scientists Invent A New Category Of Genome Engineering Technology: Gene WritingBy PR NewswireJul 7, 2020 8:00 AM EDT
INVESTINGPfizer Shares Surge After Positive Results From Early Coronavirus Vaccine StudyBy Martin BaccardaxJul 1, 2020 9:38 AM EDT
PRESS RELEASESElizabeth Tallett Joins Moderna's Board Of DirectorsBy Business WireJul 1, 2020 8:00 AM EDT
INVESTINGCan Gilead Sciences Retest $85 High on Remdesivir Pricing Update?By Bret KenwellJun 29, 2020 1:59 PM EDT
INVESTINGVaxart Oral Virus Vaccine Chosen by U.S. for Challenge StudyBy Dan WeilJun 26, 2020 9:29 AM EDT
INVESTINGVaccine Maker ETF Climbs on Trump's Positive ProclamationBy Tony OwusuJun 25, 2020 12:52 PM EDT
PRESS RELEASESModerna And Catalent Announce Collaboration For Fill-Finish Manufacturing Of Moderna's COVID-19 Vaccine CandidateBy Business WireJun 25, 2020 7:30 AM EDT
PRESS RELEASESModerna And Catalent Announce Collaboration For Fill-Finish Manufacturing Of Moderna's COVID-19 Vaccine CandidateBy Business WireJun 25, 2020 7:30 AM EDT
JIM CRAMERTime to Trim Stocks: Jim Cramer's Mad Money Recap (6/24/20)By Scott RuttJun 25, 2020 7:55 AM EDT
JIM CRAMERWhole New Game: Cramer's 'Mad Money' Recap (Tuesday 6/23/20)By Scott RuttJun 23, 2020 8:58 PM EDT
VideoSurvey: Vaccine Is Far Off, Second Virus Wave Will Hurt, Life Science Execs SayJun 23, 2020 4:33 PM EDT
PRESS RELEASESModerna To Present At BMO 2020 Prescriptions For Success Healthcare ConferenceBy Business WireJun 16, 2020 8:00 AM EDT
INVESTINGStock Market Today With Jim Cramer: Wear Your Masks AmericaBy Danny PetersonJun 16, 2020 9:51 AM EDT
INVESTINGModerna Said to Get Israeli Interest in Covid-19 VaccineBy Scott Van VoorhisJun 15, 2020 12:06 PM EDT
